Home

TEVA

Par Pharmaceuticals - Buried in the Generic Drugs Battlefield

By MagicDiligence on Thu, 2011-05-12 08:49
(via www.magicdiligence.com)

Par Pharmaceuticals is one of the smaller soldiers in the highly competitive generic drugs industry. Despite an excellent industry outlook, it will be an uphill battle for Par to generate outsized economic returns.

Advertisement:

Geoff Gannon Interviews Asif Suria of SINLetter

By GeoffGannon on Sun, 2010-07-11 17:32
(via www.investorquestionspodcast.com)

Geoff Gannon interviews Asif Suria, author of the free investment newsletter SINLetter. In this 29 minute interview, Asif discusses stocks including Activision (ATVI), Glu Mobile (GLUU), LionsGate (LGF), Marcus (MCS), and Teva (TEVA).

Magic Formula Stock Review: Impax Labratories (IPXL)

By MagicDiligence on Thu, 2010-05-13 08:35
(via www.magicdiligence.com)

Impax Pharmaceuticals is a generic drug maker. While the company is a "Magic Formula mirage" due to the 8-week generic Flomax exclusivity period, it still is an attractive Magic Formula stock for a variety of reasons.

Magic Formula Stock Review: Endo Pharmaceuticals (ENDP)

By MagicDiligence on Wed, 2010-04-21 08:38
(via www.magicdiligence.com)

Endo Pharmaceuticals is a highly profitable specialty drug maker specializing in pain killers such as Lidoderm, Opana, and Percocet. While the outlook is very good for the next few years, major patent cliffs and pipeline problems could keep the valuation lower than normal.